ArticleInternational journal of clinical and experimental pathology2015

CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression.

L H Zhao et al.PubMed ↗Full text ↗

No numbers read from the abstract.